Vireo Growth Inc. SEC filings VREOF
Vireo Growth Inc. has 362 filings in SEC EDGAR's recent list, going back to Apr 1, 2019. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, agreement ended, new debt, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 4, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 3, 2026 |
| EFFECT | Filing | Nov 2, 2026 | — |
| 424B3 | Prospectus | Nov 2, 2026 | — |
| S-4/A | Filing | Oct 30, 2026 | — |
| 425 | Filing | Oct 22, 2026 | — |
| S-4 | Registration for a merger or exchange | Oct 9, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
|
Oct 8, 2026 | Oct 2, 2026 |
| D | Filing | Oct 7, 2026 | — |
| D | Filing | Oct 2, 2026 | — |
| 425 | Filing | Aug 28, 2026 | — |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Aug 26, 2026 | Aug 21, 2026 |
| 425 | Filing | Aug 26, 2026 | — |
| 425 | Filing | Aug 25, 2026 | — |
| D | Filing | Aug 24, 2026 | — |
| 425 | Filing | Aug 18, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 18, 2026 | Aug 13, 2026 |
| 425 | Filing | Aug 18, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 425 | Filing | Aug 13, 2026 | — |
| 425 | Filing | Aug 13, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Regulation FD disclosure
|
Aug 13, 2026 | Aug 7, 2026 |
| 425 | Filing | Aug 12, 2026 | — |
| 425 | Filing | Aug 11, 2026 | — |
| 425 | Filing | Aug 11, 2026 | — |
| 425 | Filing | Aug 11, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Aug 5, 2026 | Jul 30, 2026 |
| 425 | Filing | Jul 30, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jul 30, 2026 | Jul 26, 2026 |
| 425 | Filing | Jul 27, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 27, 2026 | Jul 26, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 23, 2026 | Jul 19, 2026 |
| D | Filing | Jun 29, 2026 | — |
| D | Filing | Jun 22, 2026 | — |
| 8-K/A | Amended current report | Jun 18, 2026 | Apr 8, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 18, 2026 | Jun 14, 2026 |
| 8-K/A | Amended current report | Jun 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jun 11, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 11, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Auditor change, Regulation FD disclosure
|
Jun 9, 2026 | Jun 5, 2026 |
| 3 | Initial insider ownership | Jun 8, 2026 | May 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | May 29, 2026 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
May 29, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 5, 2026 | Apr 29, 2026 |
| S-3 | Shelf registration | Apr 23, 2026 | — |
| D | Filing | Apr 22, 2026 | — |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | May 29, 2026 |
| D | Filing | Apr 16, 2026 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Apr 14, 2026 | Apr 8, 2026 |
| 3 | Initial insider ownership | Apr 7, 2026 | Apr 3, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 6, 2026 | May 29, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Apr 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 30, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Regulation FD disclosure
|
Mar 25, 2026 | Mar 19, 2026 |
| 10-K | Annual report | Mar 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2026 | Mar 17, 2026 |
| D | Filing | Jan 12, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 30, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Dec 29, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Nov 13, 2025 |
| 4 | Insider transaction | Dec 30, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 29, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 22, 2025 | Dec 16, 2025 |
| EFFECT | Filing | Dec 19, 2025 | — |
| 424B3 | Prospectus | Dec 19, 2025 | — |
| CORRESP | Letter to the SEC | Dec 18, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 10, 2025 | Nov 13, 2025 |
| S-3 | Shelf registration | Dec 9, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 3, 2025 | Oct 29, 2025 |
| 424B3 | Prospectus | Oct 28, 2025 | — |
| D | Filing | Oct 23, 2025 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Oct 14, 2025 | Oct 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 8, 2025 | Oct 2, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 19, 2025 | — |
| 4 | Insider transaction | Sep 3, 2025 | Aug 31, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Aug 31, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 7, 2025 |
| S-8 | Employee stock plan registration | Aug 18, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K/A | Amended current report | Aug 8, 2025 | Jun 5, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Aug 1, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2025 | — |
| EFFECT | Filing | Jul 24, 2025 | — |
| 424B3 | Prospectus | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 23, 2025 | — |
| D | Filing | Jul 18, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2025 | — |
| S-3 | Shelf registration | Jul 15, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Jul 11, 2025 | Jul 7, 2025 |
| 4 | Insider transaction | Jul 9, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Regulation FD disclosure
|
Jun 12, 2025 | Jun 6, 2025 |
| 8-K/A |
Amended current report
New debt
|
Jun 12, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Listing notice, Regulation FD disclosure
|
Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | May 23, 2025 | — |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Listing notice, Officer or director change, Regulation FD disclosure
|
May 12, 2025 | May 9, 2025 |
| ARS | Annual report to shareholders | May 9, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 9, 2025 | — |
| DEF 14A | Proxy statement | May 9, 2025 | Jun 20, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 30, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 22, 2025 | — |
| 4 | Insider transaction | Apr 8, 2025 | Apr 4, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 28, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 21, 2025 | Mar 19, 2025 |
| DEFM14C | Filing | Mar 21, 2025 | — |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Mar 20, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Nov 1, 2024 |
| PREM14C | Filing | Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2025 | Mar 6, 2025 |
| PRE 14C | Filing | Mar 7, 2025 | Mar 7, 2025 |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Aug 23, 2024 |
| 4 | Insider transaction | Feb 25, 2025 | Aug 23, 2024 |
| 4 | Insider transaction | Feb 25, 2025 | Aug 23, 2024 |
| 4 | Insider transaction | Feb 25, 2025 | Aug 23, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 27, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 17, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 17, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 10, 2025 | — |
| 4/A | Ownership document | Jan 8, 2025 | Dec 17, 2024 |
| D | Filing | Jan 7, 2025 | — |
| 8-K/A |
Amended current report
Material agreement, Regulation FD disclosure
|
Jan 6, 2025 | Dec 17, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 3, 2025 | Dec 27, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 31, 2024 | — |
| 4/A | Form 4/a | Dec 23, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Material agreement, Listing notice, Officer or director change, Regulation FD disclosure
|
Dec 23, 2024 | Dec 17, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 17, 2024 |
| 3 | Initial insider ownership | Dec 23, 2024 | Dec 17, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 19, 2024 | — |
| 4 | Insider transaction | Dec 19, 2024 | Dec 17, 2024 |
| 4 | Insider transaction | Dec 19, 2024 | Dec 17, 2024 |
| 3 | Initial insider ownership | Dec 19, 2024 | Dec 17, 2024 |
| 4 | Insider transaction | Dec 19, 2024 | Dec 17, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Oct 10, 2024 |
| 424B3 | Prospectus | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| D | Filing | Nov 12, 2024 | — |
| 424B3 | Prospectus | Nov 7, 2024 | — |
| 424B3 | Prospectus | Nov 7, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Nov 7, 2024 | Nov 1, 2024 |
| EFFECT | Filing | Oct 24, 2024 | — |
| CORRESP | Letter to the SEC | Oct 22, 2024 | — |
| S-3/A | Filing | Oct 16, 2024 | — |
| CORRESP | Letter to the SEC | Oct 16, 2024 | — |
| 3 | Initial insider ownership | Oct 15, 2024 | Oct 10, 2024 |
| 8-K |
Current report
Agreement ended, Officer or director change, Regulation FD disclosure
|
Oct 15, 2024 | Oct 9, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Aug 23, 2024 |
| UPLOAD | Letter from the SEC | Oct 4, 2024 | — |
| S-3 | Shelf registration | Sep 24, 2024 | — |
| D | Filing | Aug 20, 2024 | — |
| 424B3 | Prospectus | Aug 7, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 424B3 | Prospectus | Aug 6, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Aug 6, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Aug 2, 2024 | Jul 31, 2024 |
| 424B3 | Prospectus | Jul 2, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 2, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 1, 2024 | Jun 25, 2024 |
| 424B3 | Prospectus | Jun 24, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 14, 2024 |
| 424B3 | Prospectus | Jun 20, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jun 20, 2024 | Jun 14, 2024 |
| 424B3 | Prospectus | Jun 6, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jun 6, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 424B3 | Prospectus | May 10, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VREOF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Minneapolis, MN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1771706
- Former names
- Goodness Growth Holdings, Inc. (until Jun 24, 2024); Vireo Health International, Inc. (until May 14, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.